ArticleClinical hematology international2022

FIRE Study: Real-World Effectiveness and Safety of Ibrutinib in Clinical Practice in Patients with CLL and MCL.

Caroline Dartigeas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.